{"resourceType": "Composition", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/baseline-measure-report"], "versionId": "3", "lastUpdated": "2025-12-11T11:07:53.202Z"}, "contained": [{"resourceType": "EvidenceVariable", "id": "NCT03421379-BaselineMeasure-0", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Age, Continuous", "status": "active", "definition": {"concept": {"text": "Age, Continuous"}}, "classifier": [{"text": "Baseline Measure"}], "timing": {"offsetDuration": {"value": 0}}, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-variable-handling-not-specified", "display": "Evidence variable handling not specified"}]}}], "handling": "evidence-variable-handling-not-specified"}, {"resourceType": "EvidenceVariable", "id": "NCT03421379-BaselineMeasure-1", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Sex: Female, Male", "status": "active", "definition": {"concept": {"text": "Sex: Female, Male"}}, "category": [{"name": "Female"}, {"name": "Male"}], "classifier": [{"text": "Baseline Measure"}], "timing": {"offsetDuration": {"value": 0}}, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-variable-handling-not-specified", "display": "Evidence variable handling not specified"}]}}], "handling": "evidence-variable-handling-not-specified"}, {"resourceType": "EvidenceVariable", "id": "NCT03421379-BaselineMeasure-2", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Ethnicity (NIH/OMB)", "status": "active", "definition": {"concept": {"text": "Ethnicity (NIH/OMB)"}}, "category": [{"name": "Hispanic or Latino"}, {"name": "Not Hispanic or Latino"}, {"name": "Unknown or Not Reported"}], "classifier": [{"text": "Baseline Measure"}], "timing": {"offsetDuration": {"value": 0}}, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-variable-handling-not-specified", "display": "Evidence variable handling not specified"}]}}], "handling": "evidence-variable-handling-not-specified"}, {"resourceType": "EvidenceVariable", "id": "NCT03421379-BaselineMeasure-3", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Race (NIH/OMB)", "status": "active", "definition": {"concept": {"text": "Race (NIH/OMB)"}}, "category": [{"name": "American Indian or Alaska Native"}, {"name": "Asian"}, {"name": "Native Hawaiian or Other Pacific Islander"}, {"name": "Black or African American"}, {"name": "White"}, {"name": "More than one race"}, {"name": "Unknown or Not Reported"}], "classifier": [{"text": "Baseline Measure"}], "timing": {"offsetDuration": {"value": 0}}, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-variable-handling-not-specified", "display": "Evidence variable handling not specified"}]}}], "handling": "evidence-variable-handling-not-specified"}, {"resourceType": "EvidenceVariable", "id": "NCT03421379-BaselineMeasure-4", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Region of Enrollment", "status": "active", "definition": {"concept": {"text": "Region of Enrollment"}}, "category": [{"name": "Japan"}], "classifier": [{"text": "Baseline Measure"}], "timing": {"offsetDuration": {"value": 0}}, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-variable-handling-not-specified", "display": "Evidence variable handling not specified"}]}}], "handling": "evidence-variable-handling-not-specified"}, {"resourceType": "Group", "id": "BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"]}, "name": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution", "description": "A single dose of 3 mg glucagon nasal powder was administered intranasally", "type": "person", "membership": "enumerated", "code": {"text": "Participants"}, "quantity": 33, "characteristic": [{"code": {"text": "Research Study from which this is a baseline group"}, "valueReference": {"display": "NCT03421379"}, "exclude": false}]}, {"resourceType": "Group", "id": "BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"]}, "name": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder", "description": "A single dose of 1 mg glucagon hydrochloride solution was administered IM", "type": "person", "membership": "enumerated", "code": {"text": "Participants"}, "quantity": 39, "characteristic": [{"code": {"text": "Research Study from which this is a baseline group"}, "valueReference": {"display": "NCT03421379"}, "exclude": false}]}, {"resourceType": "Group", "id": "BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"]}, "name": "Total", "description": "Total of all reporting groups", "type": "person", "membership": "enumerated", "code": {"text": "Participants"}, "quantity": 72, "characteristic": [{"code": {"text": "Research Study from which this is a baseline group"}, "valueReference": {"display": "NCT03421379"}, "exclude": false}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-0-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_0_BG000", "title": "Age, Continuous for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG000", "type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-0", "type": "EvidenceVariable", "display": "Age, Continuous"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000573", "display": "mean"}]}, "quantity": {"value": 41.7, "unit": "years"}, "sampleSize": {"knownDataCount": 33}, "attributeEstimate": [{"type": {"text": "Standard Deviation"}, "quantity": {"value": 11.6, "unit": "years"}}]}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-0-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_0_BG001", "title": "Age, Continuous for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG001", "type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-0", "type": "EvidenceVariable", "display": "Age, Continuous"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000573", "display": "mean"}]}, "quantity": {"value": 57.5, "unit": "years"}, "sampleSize": {"knownDataCount": 39}, "attributeEstimate": [{"type": {"text": "Standard Deviation"}, "quantity": {"value": 9.2, "unit": "years"}}]}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-0-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_0_BG002", "title": "Age, Continuous for Total at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG002", "type": "Group", "display": "Total"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-0", "type": "EvidenceVariable", "display": "Age, Continuous"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000573", "display": "mean"}]}, "quantity": {"value": 50.2, "unit": "years"}, "sampleSize": {"knownDataCount": 72}, "attributeEstimate": [{"type": {"text": "Standard Deviation"}, "quantity": {"value": 13, "unit": "years"}}]}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-1-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_1_BG000", "title": "Sex: Female, Male for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG000", "type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-1", "type": "EvidenceVariable", "display": "Sex: Female, Male"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Female"}, "quantity": {"value": 13, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Male"}, "quantity": {"value": 20, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-1-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_1_BG001", "title": "Sex: Female, Male for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG001", "type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-1", "type": "EvidenceVariable", "display": "Sex: Female, Male"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Female"}, "quantity": {"value": 9, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Male"}, "quantity": {"value": 30, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-1-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_1_BG002", "title": "Sex: Female, Male for Total at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG002", "type": "Group", "display": "Total"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-1", "type": "EvidenceVariable", "display": "Sex: Female, Male"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Female"}, "quantity": {"value": 22, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Male"}, "quantity": {"value": 50, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-2-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_2_BG000", "title": "Ethnicity (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG000", "type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-2", "type": "EvidenceVariable", "display": "Ethnicity (NIH/OMB)"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Hispanic or Latino"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Not Hispanic or Latino"}, "quantity": {"value": 33, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Unknown or Not Reported"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-2-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_2_BG001", "title": "Ethnicity (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG001", "type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-2", "type": "EvidenceVariable", "display": "Ethnicity (NIH/OMB)"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Hispanic or Latino"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Not Hispanic or Latino"}, "quantity": {"value": 39, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Unknown or Not Reported"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-2-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_2_BG002", "title": "Ethnicity (NIH/OMB) for Total at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG002", "type": "Group", "display": "Total"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-2", "type": "EvidenceVariable", "display": "Ethnicity (NIH/OMB)"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Hispanic or Latino"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Not Hispanic or Latino"}, "quantity": {"value": 72, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Unknown or Not Reported"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-3-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_3_BG000", "title": "Race (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG000", "type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-3", "type": "EvidenceVariable", "display": "Race (NIH/OMB)"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "American Indian or Alaska Native"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Asian"}, "quantity": {"value": 33, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Native Hawaiian or Other Pacific Islander"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Black or African American"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "White"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "More than one race"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Unknown or Not Reported"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 33}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-3-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_3_BG001", "title": "Race (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG001", "type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-3", "type": "EvidenceVariable", "display": "Race (NIH/OMB)"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "American Indian or Alaska Native"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Asian"}, "quantity": {"value": 39, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Native Hawaiian or Other Pacific Islander"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Black or African American"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "White"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "More than one race"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Unknown or Not Reported"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 39}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-3-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_3_BG002", "title": "Race (NIH/OMB) for Total at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG002", "type": "Group", "display": "Total"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-3", "type": "EvidenceVariable", "display": "Race (NIH/OMB)"}}], "statistic": [{"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "American Indian or Alaska Native"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Asian"}, "quantity": {"value": 72, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Native Hawaiian or Other Pacific Islander"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Black or African American"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "White"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "More than one race"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}, {"statisticType": {"coding": [{"system": "https://fevir.net/sevco", "code": "STATO:0000047", "display": "count"}], "text": "Count of Participants"}, "category": {"text": "Unknown or Not Reported"}, "quantity": {"value": 0, "unit": "Participants"}, "sampleSize": {"knownDataCount": 72}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-4-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_4_BG000", "title": "Region of Enrollment for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG000", "type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-4", "type": "EvidenceVariable", "display": "Region of Enrollment"}}], "statistic": [{"statisticType": {"text": "Number (see protocol for details)"}, "category": {"text": "Japan"}, "quantity": {"value": 33, "unit": "participants"}, "sampleSize": {"knownDataCount": 33}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-4-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_4_BG001", "title": "Region of Enrollment for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG001", "type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-4", "type": "EvidenceVariable", "display": "Region of Enrollment"}}], "statistic": [{"statisticType": {"text": "Number (see protocol for details)"}, "category": {"text": "Japan"}, "quantity": {"value": 39, "unit": "participants"}, "sampleSize": {"knownDataCount": 39}}]}, {"resourceType": "Evidence", "id": "NCT03421379-BaselineMeasure-4-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_4_BG002", "title": "Region of Enrollment for Total at baseline in NCT03421379", "status": "active", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "variableRole": "population", "observed": {"reference": "#BG002", "type": "Group", "display": "Total"}}, {"variableRole": "outcome", "observed": {"reference": "#NCT03421379-BaselineMeasure-4", "type": "EvidenceVariable", "display": "Region of Enrollment"}}], "statistic": [{"statisticType": {"text": "Number (see protocol for details)"}, "category": {"text": "Japan"}, "quantity": {"value": 72, "unit": "participants"}, "sampleSize": {"knownDataCount": 72}}]}], "identifier": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}], "text": "FEvIR Object Identifier"}, "system": "https://fevir.net/FOI", "value": "399872", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT03421379-baseline-measure-report", "assigner": {"display": "Computable Publishing LLC"}}], "status": "final", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "BaselineMeasureReport", "display": "BaselineMeasureReport"}], "text": "Baseline Measure Report"}, "author": [{"display": "[No author listed.]"}], "title": "Baseline Characteristics Report for NCT03421379", "id": "399872", "url": "https://fevir.net/resources/Composition/399872", "date": "2025-12-11T11:07:53.202Z", "custodian": {"reference": "Organization/118079", "type": "Organization", "display": "Computable Publishing LLC"}, "relatesTo": [{"type": "cite-as", "targetMarkdown": "Baseline Characteristics Report for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: [No author listed.] [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 399872. Revised 2025-12-11. Available at: https://fevir.net/resources/Composition/399872. Computable resource at: https://fevir.net/resources/Composition/399872#json."}], "section": [{"title": "Baseline Reporting Population Description", "code": {"text": "BaselinePopulationDescription"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">All randomized participants who received at least one dose of study drug.</div>"}}, {"title": "Baseline Group List", "code": {"text": "BaselineGroupList"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Glucagon Nasal Powder/Glucagon Hydrochloride Solution, Glucagon Hydrochloride Solution/Glucagon Nasal Powder, Total</div>"}, "entry": [{"reference": "#BG000", "type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"}, {"reference": "#BG001", "type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"}, {"reference": "#BG002", "type": "Group", "display": "Total"}]}, {"title": "Age, Continuous", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "#NCT03421379-BaselineMeasure-0", "type": "EvidenceVariable", "display": "Age, Continuous"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "#NCT03421379-BaselineMeasure-0-BG000", "type": "Evidence", "display": "Age, Continuous for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-0-BG001", "type": "Evidence", "display": "Age, Continuous for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-0-BG002", "type": "Evidence", "display": "Age, Continuous for Total at baseline in NCT03421379"}]}, {"title": "Sex: Female, Male", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "#NCT03421379-BaselineMeasure-1", "type": "EvidenceVariable", "display": "Sex: Female, Male"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "#NCT03421379-BaselineMeasure-1-BG000", "type": "Evidence", "display": "Sex: Female, Male for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-1-BG001", "type": "Evidence", "display": "Sex: Female, Male for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-1-BG002", "type": "Evidence", "display": "Sex: Female, Male for Total at baseline in NCT03421379"}], "section": [{"title": "Baseline Measure Calculate Percent", "code": {"text": "BaselineMeasureCalculatePct"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>"}}]}, {"title": "Ethnicity (NIH/OMB)", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "#NCT03421379-BaselineMeasure-2", "type": "EvidenceVariable", "display": "Ethnicity (NIH/OMB)"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "#NCT03421379-BaselineMeasure-2-BG000", "type": "Evidence", "display": "Ethnicity (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-2-BG001", "type": "Evidence", "display": "Ethnicity (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-2-BG002", "type": "Evidence", "display": "Ethnicity (NIH/OMB) for Total at baseline in NCT03421379"}], "section": [{"title": "Baseline Measure Calculate Percent", "code": {"text": "BaselineMeasureCalculatePct"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>"}}]}, {"title": "Race (NIH/OMB)", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "#NCT03421379-BaselineMeasure-3", "type": "EvidenceVariable", "display": "Race (NIH/OMB)"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "#NCT03421379-BaselineMeasure-3-BG000", "type": "Evidence", "display": "Race (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-3-BG001", "type": "Evidence", "display": "Race (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-3-BG002", "type": "Evidence", "display": "Race (NIH/OMB) for Total at baseline in NCT03421379"}], "section": [{"title": "Baseline Measure Calculate Percent", "code": {"text": "BaselineMeasureCalculatePct"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>"}}]}, {"title": "Region of Enrollment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "#NCT03421379-BaselineMeasure-4", "type": "EvidenceVariable", "display": "Region of Enrollment"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "#NCT03421379-BaselineMeasure-4-BG000", "type": "Evidence", "display": "Region of Enrollment for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-4-BG001", "type": "Evidence", "display": "Region of Enrollment for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"}, {"reference": "#NCT03421379-BaselineMeasure-4-BG002", "type": "Evidence", "display": "Region of Enrollment for Total at baseline in NCT03421379"}]}]}